News | April 11, 2025
Orchid Pharma to settle disputes with DBS Bank
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The European regulator will conduct a re-inspection of the facility to verify the compliance
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Subscribe To Our Newsletter & Stay Updated
